More than 25,000 bottles of blood pressure medication have been recalled after they failed safety tests. Patients are being urged to contact their pharmacist to check their medication.
In June, the same company issued a recall for 11,460 bottles of the same drug, taking the total to 25,027 bottles affected. Both recalls were issued for the same reason, reports Healthline.
The FDA enforcement notice said the pills failed dissolution specification, which means they are not releasing the medication into the body as intended.
Chlorthalidone is a ‘water tablet’, aka a diuretic, often used to treat high blood pressure, fluid retention, heart failure, and diabetes insipidus. Usually, patients are told to take the pill at breakfast to avoid disrupting their sleep.
Three batches of the drug, which all expire in April 2027, are subject to the recall. The pills are light yellow in colour and have ‘103’ stamped on one side, but are blank on the other.
Exact details of the batches have been released so patients can call the pharmacy which dispensed their last prescription to check the batch numbers and see if they are subject to the recall.
The batches affected are:
Recall initiated on September 3, 2026; 13,567 bottles affected.
June 2026 recall (recall number D-0610-2026)
Recall initiated on June 5, 2026; 11,460 bottles affected.
This story originally appeared on Express.co.uk
